<code id='69D196ED6E'></code><style id='69D196ED6E'></style>
    • <acronym id='69D196ED6E'></acronym>
      <center id='69D196ED6E'><center id='69D196ED6E'><tfoot id='69D196ED6E'></tfoot></center><abbr id='69D196ED6E'><dir id='69D196ED6E'><tfoot id='69D196ED6E'></tfoot><noframes id='69D196ED6E'>

    • <optgroup id='69D196ED6E'><strike id='69D196ED6E'><sup id='69D196ED6E'></sup></strike><code id='69D196ED6E'></code></optgroup>
        1. <b id='69D196ED6E'><label id='69D196ED6E'><select id='69D196ED6E'><dt id='69D196ED6E'><span id='69D196ED6E'></span></dt></select></label></b><u id='69D196ED6E'></u>
          <i id='69D196ED6E'><strike id='69D196ED6E'><tt id='69D196ED6E'><pre id='69D196ED6E'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:13
          Mike Belleme for STAT

          Five years after investor-owned HCA Healthcare took over an esteemed nonprofit hospital in North Carolina, Medicare is threatening to cut off payment for any services it provides seniors.

          The rare and dramatic move follows a Medicare revelation that patient safety is in “immediate jeopardy” at Mission Hospital in Asheville. That designation is the most severe the agency can hand out. HCA has just a few weeks to fix the problems or lose its Medicare funding.

          advertisement

          “If on average Medicare pays roughly one-third of your revenue, if they stop paying you, you will die,” said Michael Millenson, a national patient safety expert and president of the consultancy Health Quality Advisors. “That’s why it gets immediate attention from the hospital management, because it’s a death threat.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          Merck drug for rare lung condition set for approval in U.S.
          Merck drug for rare lung condition set for approval in U.S.

          AdobeTheFoodandDrugAdministrationisexpectedtoapproveMerck’sdrugtotreatararelungdisordercalledpulmona

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Covid misinformation case heads to Supreme Court

          AnnaMoneymaker/GettyImagesWASHINGTON—TheSupremeCourtwillthisMarchhearargumentscenteredonthegovernmen